Effect of the deferoxamine mesylate on the prognosis of patients with intracerebral hemorrhage
10.3760/cma.j.issn.1008-6315.2016.10.001
- VernacularTitle:甲磺酸去铁胺对脑出血患者预后的影响
- Author:
Wei ZHAO
;
Chunpeng ZHU
;
Yao YU
;
Yajing HAN
;
Xuguang GAO
- Publication Type:Journal Article
- Keywords:
Intracerebral hemorrhage;
Deferoxamine Mesylate;
Prognosis
- From:
Clinical Medicine of China
2016;32(10):865-867,868
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of the deferoxamine mesylate on the prognosis of patients with intracerebral hemorrhage(ICH) after one year. Methods From February 2013 to May 2014,spontaneous ICH patients diagnosed by computed tomography ( CT ) within 18 hours of onset in Mancheng District Hospital of Baoding were evaluated. Patients were randomly divided into experimental group and control group. The treatment of the two groups was similar except that the experimental group received deferoxamine mesylate. Patients were e?valuated by CT and neurology scale( NIHSS scale,GCS scale) at the time of admission and followed up for the first year by the RANKIN( mRS) scale. All clinical data of the two groups were compared. Results Forty?two patients were included in the study, including 21 cases in the experimental group and 21 cases in the control group,there was no significant difference in baseline data between the two groups at admission. There were 6 pa?tients with mRS ≥3 in the experimental group, and 6 patients with mRS ≥3 in the control group after one year. There was no statistically significant difference in the distribution of mRS score between the two groups after one year admission( P=1. 000) . Conclusion There may be no helpful on the prognosis of patients with intrace?rebral hemorrhage by intravenous infusion of deferoxamine mesylate,the further study is needed.
